Neonatal screening for severe combined immune deficiency

Current Opinion in Allergy and Clinical Immunology

Volumn 7, Issue 6, 2007, Pages 522-527

  Puck, Jennifer M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone marrow transplantation; Early diagnosis; Hematopoietic stem cell transplantation; Live vaccine; Newborn screening; Primary immunodeficiency

Indexed keywords

CD3 ANTIGEN; CD45 ANTIGEN; INTERLEUKIN 7; T LYMPHOCYTE RECEPTOR;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; COMBINED IMMUNODEFICIENCY; DISEASE COURSE; EARLY DIAGNOSIS; ENZYME REPLACEMENT; EVIDENCE BASED PRACTICE; GENE MUTATION; GENE THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; LONG TERM CARE; LYMPHOCYTE COUNT; MORBIDITY; NEWBORN MORTALITY; NEWBORN SCREENING; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 35948933873     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e3282f14a2a     Document Type: Review

References (29)

1. Puck JM. X-linked severe combined immunodeficiency. In: Ochs H, Smith CIE, Puck JM, editors. Primary immunodeficiency diseases: a molecular and genetic approach, 2nd ed. New York: Oxford University Press; 2007. pp. 123-136.
2. Buckley RH. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 2004; 22:625-655.
3. O'Reilly RJ, Friedrich W, Small TN. Transplantation approaches for severe combined immunodeficiency disease, Wiskott-Aldrich syndrome, and other lethal genetic combine immunodeficiency disorders. In: Forman SJ, Blume KG, Thomas ED, editors. Bone marrow transplantation. Boston: Blackwell Scientific Publications; 1994. pp. 849-867.
4. Knutsen AP, Wall DA. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience. J Clin Immunol 2000; 20:466-476.
5. Smogorzewska EM, Brooks J, Annett G, et al. T cell depleted haploidentical bone marrowtransplantation for the treatment of children with severe combined immunodeficiency. Arch Immunol Ther Exp (Warsz) 2000; 48:111-118.
6. Antoine C, Muller S, Cant A, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 2003; 361:553-560.
7. Grunebaum E, Mazzolari E, Porta F, et al. Bone marrow transplantation for severe combined immune deficiency. JAMA 2006; 295:508-518. Combined Canadian and Italian retrospective data on bone marrow transplantation for SCID, including successful use of matched unrelated cord blood as a source.
8. Buckley RH, Fischer A. Bone marrow transplantation for primary immunodeficiency diseases. In: Ochs H, Smith CIE, Puck JM, editors. Primary immunodeficiency diseases: a molecular and genetic approach, 2nd ed. New York: Oxford University Press; 2007. pp. 669-687. This is a comprehensive update on the history, methods and outcomes of transplantation treatment for SCID and other primary immunodeficiencies.
9. Cavazzana-Calvo M, Carlier F, Le Deist F, et al. Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype. Blood 2007; 109:4575-4581. This provides updated transplantation data from the large experience in a single institution.
10. Chan B, Wara D, Bastian J, et al. Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID). Clin Immunol 2005; 117:133-143.
11. Candotti F, Fischer A. Gene therapy. In: Ochs H, Smith CIE, Puck JM, editors. Primary immunodeficiency diseases: a molecular and genetic approach, 2nd ed. New York: Oxford University Press; 2007. pp. 688-705.
12. Cavazzana-Calvo M, Fischer A. Gene therapy for severe combined immunodeficiency: are we there yet? J Clin Invest 2007; 117:1457-1465. This review summarizes the status of human gene therapy trials for X-linked SCID and ADA deficient SCID and points out the successes and limitations of allogeneic transplantation for SCID.
13. Myers LA, Patel DD, Puck JM, Buckley RH. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood 2002; 99:872-878.
14. Chan K, Puck JM. Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol 2005; 115:391-398.
15. SCID Newborn Screening Working Group, Puck JM. Population-based newborn screening for severe combined immunodeficiency: steps towards implementation. J Allergy Clin Immunol (in press).
16. Wilson JM, Jungner G. Principles and practice of screening for disease. World Health Organization Public Health Papers 1968; 34:11-63.
17. Therrell BL, Johnson A, Williams D. Status of newborn screening programs in the United States. Pediatrics 2006; 117:S212-S252.
18. th August 2007]
19. Lindegren ML, Kobrynski L, Rasmussen SA, et al. Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep 2004; 53 (RR-1):1-29.
20. Laessig RH, Baker MW, Hoffman GL, Routes JM, Grossman WJ. Piloting SCID newborn screening in wisconsin using the experience from cystic fibrosis. In: Proceedings of the 2007 Newborn Screening and Genetic Testing Symposium; 7-10 May 2007; Minneapolis. Silver Spring: Association of Public Health Laboratories (in press).
21. Pass K, Green NS, Lorey F, et al. Pilot programs in newborn screening. Ment Retard Dev Disabil Res Rev 2006; 12:293-300. This outstanding review of newly introduced newborn screening tests illustrates the processes by which screening panels have been expanded to include additional conditions.
22. McGhee SA, Stiehm ER, McCabe ER. Potential costs and benefits of newborn screening for severe combined immunodeficiency. J Pediatr 2005; 147:603-608.
23. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 396:690-695.
24. Harris JM, Hazenberg MD, Poulin J-F, et al. Multiparameter evaluation of human thymic function: interpretations and caveats. Clin Immunol 2005; 115:138-146.
25. McGhee SA, Stiehm ER, Cowan M, et al. Two-tiered universal newborn screening strategy for severe combined immunodeficiency. Mol Genet Metab 2005; 86:427-430.
26. Warrington JA, Shah NA, Chen X, et al. New developments in high throughput resequencing and variation detection using high density microarrays. Hum Mutation 2002; 19:402-409.
27. Tarini BA, Chiristakis DA, Welch HG. State newborn screeing in the tandem mass spectrometry era: more tests, more false-positve results. Pediatrics 2006; 118:448-456. This paper presents the problem of false positive screening tests from a public health perspective, using metabolic screening by tandem mass spectrometry as a case in point.
28. Waisbren SE, Albers S, Amato S, et al. Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress. JAMA 2003; 290:2564-2572.
29. Mazzolari E, Forino C, Imberti L, et al. Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency. J Allergy Clin Immunol 2007; 120:892-899.